Hvivo PLC operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hvivo PLC with three other
pharmaceutical manufacturers in Europe:
Hofseth Biocare ASA
sales of 118.48 million Norwegian Kroner [US$13.76 million]
(723.50 million Russian Rubles [US$10.92 million]
Venture Life Group plc
(£16.05 million [US$20.74 million]
During the year ended December of 2017, sales at
Hvivo PLC were £10.88 million (US$14.05 million).
decrease of 45.2%
versus 2016, when the company's sales were £19.85 million.